Biogen's Aduhelm Defense Highlights Therapeutic Area Discrepancies

 
• By Jessica Merrill
  
change of direction
Biogen hopes CMS will change its decision on Aduhelm coverage • Source: Alamy

More from Medicare

More from Government Payers